Comments
The Kalyani group has set up a state-of-the-art facility for the diagnostics, treatment and research of prostrate cancer at Pune in association with Ruby Hall Clinic. The Institute for Prostate Cancer will be established and supported by Dr Ashutosh Tewari, an American urologist and oncologist.
Mr Baba Kalyani, promoter of the Institute and Chairman, Kalyani Group said, “Prostate cancer today is the second largest cause of death in males after lung cancer. Our endeavour is to create awareness about this potentially lethal disease and focus on research, early diagnosis and treatment.”
The Institute will have five distinct priority areas that will address screening and treatment, prostate cancer genomics, imaging and education.
“We will use an integrated team approach for both treatment and research. The Institute will bring together biologists, genome scientists, physicians, engineers, and computer scientists. We will build collaborations with a broader community of researchers and clinicians worldwide to help cure prostate cancer,” Dr Ashutosh Tewari said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.